Skip to content
News Center
About Us Careers News Center Contact Us Legal Video Hub Doing business with Illumina Investors Illumina for Startups

Perspectives Blog

4 min read
2021 in Genomics
By Francis deSouza , CEO December 30, 2021
2 min read
Empowering Informed Choices That Can Change Lives
By Gretchen Weightman , General Manager — Asia Pacific & Japan
June 30, 2021

Driving innovation for a healthy future

In the News

Date Publication Title
Jun 23, 2025 Endpoints News Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics
Jun 17, 2025 Forbes Illumina’s New CIO Brings R&D Mindset As AI Transforms Genomics
Jun 13, 2025 GEN Silver Anniversary of the Human Genome Project
View All Illumina News
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.